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Abstract
Cognition, negative symptoms, and depression are potential predictors of disability in 
schizophrenia. We present analyses of pooled data from four separate studies (all n>169; total 
n=821) that assessed differential aspects of disability and their potential determinants. We 
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hypothesized that negative symptoms would predict social outcomes, but not vocational 
functioning or everyday activities and that cognition and functional capacity would predict 
vocational functioning and everyday activities but not social outcomes. The samples were rated by 
clinician informants for their everyday functioning in domains of social and vocational outcomes, 
and everyday activities, examined with assessments of cognition and functional capacity, rated 
clinically with the Positive and Negative Syndrome Scale (PANSS) and self-reporting depression. 
We computed a model that tested the hypotheses described above and compared it to a model that 
predicted that negative symptoms, depression, cognition, and functional capacity had equivalent 
influences on all aspects of everyday functioning. The former, specific relationship model fit the 
data adequately and we subsequently confirmed a similar fit within all four samples. Analyses of 
the relative goodness of fit suggested that this specific model fit the data better than the more 
general, equivalent influence predictor model. We suggest that treatments aimed at cognition may 
not affect social functioning as much as other aspects of disability, a finding consistent with earlier 
research on the treatment of cognitive deficits in schizophrenia, while negative symptoms 
predicted social functioning. These relationships are central features of schizophrenia and 
treatment efforts should be aimed accordingly.
1. Introduction
Everyday functioning is commonly impaired in schizophrenia, affecting domains of social 
functioning, vocational performance, and performance of everyday activities. Even among 
those patients classified as ‘responders’ to available pharmacological and psychosocial 
treatments, disability rates are high and functional outcomes have changed minimally 
compared to success in treating psychosis (Hegarty et al., 1994). Cognitive deficits and 
negative symptoms are thought to represent the main drivers of disability, (Breier et al., 
1991; Carone et al., 1991) although influences outside of the individual such as 
opportunities and disincentives such as disability compensation meaningfully affect certain 
domains of functioning (Rosenheck et al., 2006; Harvey et al., 2009). While positive 
symptoms usually improve with treatment, or can otherwise be compensated for (Ventura et 
al. 2009) both cognitive deficits and negative symptoms receive minimal benefit despite the 
fact that current antipsychotics control psychosis to the point that clinical remission rates are 
close to 50% in some studies (Harvey and Bellack, 2009).
Moreover, negative and cognitive symptoms of schizophrenia, often present prior to the 
emergence of frank psychosis (Meyer et al., 2014), appear to be related but separable 
domains with different functional implications (Harvey et al., 2006; Couture et al., 2011). 
Ventura et al (2009) concur that cognitive and negative symptoms both predict outcome, but 
note that negative symptoms partially mediate the longitudinal relationship between 
cognition and outcome, and suggest therefore that cognition has both direct and indirect 
effects on functioning. Similarly, Lin et al. (2013) suggest that negative symptoms mediate 
the influence of cognition on outcome. Some of our own work has suggested that different 
domains of everyday functioning may not be as highly intercorrelated as previously thought 
and may also have different potential determinants. For instance, we previously reported that 
cognitive and functional capacity deficits predicted impairments in everyday activities (with 
the exception of social outcomes) and that negative symptoms were related to poor social 
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outcomes to a greater extent than to other aspects of everyday outcome (Leifker et al., 
2009). Meta-analyses have suggested that non-social cognitive deficits show less relation to 
social deficits when compared to the influence of social cognition (Green et al., 2000; Green 
et al., 2004; Fett et al., 2011), and we have found that social deficits were less responsive to 
interventions aimed at treatment of cognition and functional skills deficits compared to work 
and instrumental functions (Bowie et al., 2012). Finally, achievement of different functional 
milestones (work, residence, and social achievements) is minimally intercorrelated in 
schizophrenia, suggesting that global indices of disability may lack the requisite specificity 
(Harvey et al., 2012) and that there are likely specific predictors of impairments in different 
domains of everyday functioning.
In this paper we present analyses of a unique set of data: four separately collected datasets 
with similar methodological strategies that allowed for the evaluation of the relationship 
between three different aspects of real-world functional outcomes: social functioning, 
vocational skills, and performance of everyday activities, assessed with the same scales and 
informant strategies, and an identical set of potential determinants of functioning: 
neuropsychological test performance, performance-based measures of functional capacity, 
and negative and depressive symptoms. All four separate large-scale (n=169 in the smallest; 
total n=821) studies contribute information on the correlational relationships between 
everyday outcomes and an array of potential predictors.
These studies were conducted in five separate geographical areas (New York, Atlanta, San 
Diego, Miami, and Dallas) have no overlap of patients or clinicians, and reflect a wide range 
of demographic and ethnic variation in the patients assessed, while the same real-world 
functional outcome measure, clinical ratings, self-reports of symptoms, and functional 
capacity measures were used. Cognition was assessed with batteries that have overlap of 
identical tests in 3/4 studies and a highly similar battery in the other study. While some 
results regarding correlational aspects between symptoms, functional capacity, and everyday 
outcomes have been published from three of the studies (See below), there has never been a 
systematic comparison of the influences of negative symptoms, depression, cognition, and 
functional capacity on everyday functioning across sequentially completed studies with the 
same assessment strategies.
Based on previous research delineated above, we hypothesized that negative symptoms 
would predict social deficits, but not impairments in everyday activities and vocational 
outcomes, while cognition and functional capacity would predict deficits in everyday 
activities and vocational outcomes, but not social outcomes. This is a cross-sectional 
hypothesis in a sample of relatively chronic patients. Previous research (Ventura et al, 2015) 
has found that negative symptoms early in the course of illness predict both social 
functioning and work/school functioning at a year after initial contact, suggesting that 
influences of reductions in motivation or emotional expression have broad impacts. 
However, in a sample where the illness is already fully developed, we hypothesized that 
negative symptoms would exert a greater influence on social outcomes than everyday 
activities. We also hypothesized that depression, negative symptoms, and cognition and 
functional would exert independent influences on the real-world outcomes of interest. We 
tested this model in the sample as a whole, as well as in each of the individual subsamples. 
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We also computed a generic model, wherein cognition and functional capacity, depression, 
and negative symptoms were hypothesized to be equally important for the prediction of all 
elements of real-world outcomes in the database.
We tested several hypotheses in these analyses of the substantive model and its comparator 
model;
1. A model specifying that negative symptoms will be have a more substantial 
predictive influence on social deficits than cognition or functional capacity will be 
the best fit to that data.
2. A model specifying that cognition and functional capacity will predict everyday 
activities and vocational outcomes more substantially than social outcomes will be 
the best fit to the data.
3. Depression will impact all aspects of functional outcomes.
2. Methods
2.1. Participants
The data are part of four study cohorts collected in five different geographical areas, aimed 
at identifying the course and correlates of change in functional status as well as the optimal 
method for rating everyday functioning among schizophrenia outpatients.
The study participants were patients (n=821) with schizophrenia or schizoaffective disorder 
receiving treatment at one of several different outpatient service delivery systems in Atlanta, 
Dallas, Miami, San Diego and New York City. Atlanta patients were either recruited at a 
private psychiatric rehabilitation program (Skyland Trail) or from the outpatient population 
at the Atlanta VA Medical Center. San Diego patients were recruited from the UCSD 
Outpatient Psychiatric Services clinic, a large public mental health clinic and other local 
community clinics, or by self-referral. Miami patients were recruited from the outpatient 
services at the University of Miami Miller School of Medicine. The Mount Sinai Sample 
recruitment was conducted at the Bronx VA Medical Center, an outpatient clinic at a New 
York State Psychiatric Hospital, or Mount Sinai School of Medicine. The Dallas sample was 
collected from Metrocare Services, a large non-profit provider of mental health services in 
Dallas County, and other outpatient services associated with the University of Texas 
Southwestern Medical (UTSW) Center. All research participants provided signed informed 
consent according to standards approved by the responsible local Institutional Review 
Boards.
Patients from Atlanta, San Diego, and Miami were participants in one of two phases of the 
Validation of Everyday Real World Outcomes Study (VALERO), parts 1 or 2. UCSD and 
Atlanta patients participated in VALERO 1, and UCSD, Atlanta and Miami patients 
participated in VALERO 2, which was started 6 months after the conclusion of data analysis 
of VALERO 1. Dallas patients, as well as a completely new sample of Miami patients were 
participants in phase I of SCOPE (Pinkham et al., 2014) study. We examined the data from 
these studies based on the study in which they were collected. These data were collected 
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between July 2007 and May 2014. The Mount Sinai Sample was collected between March 
2003 and June of 2008.
All enrollees completed a structured diagnostic interview, administered by a trained 
interviewer. The Structured Clinical Interview for the DSM (SCID; First et al., 2002) was 
used at the Atlanta sites, the Mini International Neuropsychiatric Interview, 6th Edition 
(Sheehan et al., 1998) in Dallas, San Diego, and Miami, and the Comprehensive Assessment 
of Symptoms and History (CASH) (Andreasen et al., 1992) in New York; all diagnoses were 
verified in local consensus procedures. Screening also included global cognitive function 
and premorbid functioning measured with the Mini-Mental State Examination (Folstein et 
al., 1975) and the Wide Range Achievement Test, 3rd Edition (WRAT3; Wilkinson, 1993) 
Recognition Reading subtest. Patients were excluded for a history of traumatic brain injury, 
brain disease such as seizure disorder or neurodegenerative condition, a MMSE score below 
18 in the Mt. Sinai Sample, a reading score below the 6th grade in all samples, or the 
presence of another DSM-IV diagnosis that would exclude the diagnosis of schizophrenia. 
To capture a comprehensive array of participants reflective of real-world realities, comorbid 
substance use disorders were not an exclusion criterion. Rather, patients who appeared 
intoxicated were rescheduled. No inpatients were recruited but patients who resided in a 
variety of residential facilities including unsupported, supported, or supervised facilities 
were eligible. Informants were not screened for psychopathology or substance abuse. These 
procedures were described in previous publications (Pinkham et al., 2014; Durand et al., 
2014; Bowie et al., 2008).
2.2. Assessment Strategy
Following screening, the test battery was completed. All raters received extensive training in 
performing all of the assessments and every three months their performance was re-
evaluated. Although the SCOPE study was aimed at social cognition, social cognition 
measures are not presented in this report.
Real world functioning was rated with the same rating scale. In the Mt Sinai study and in 
VALERO 2, ratings were generated by a high-contact clinician, either a case manager, a 
residential facility manager, or a psychotherapist who stated that they knew patient “very 
well”. In VALERO 1 and SCOPE, high contact clinicians and friends or relatives of the 
patients provided information to a clinical rater. The rater then generated ratings for the 
patients’ everyday functioning.
2.2.1. Cognition—For the Mt. Sinai study, which preceded the finalization of the 
MATRICS consensus cognitive battery (MCCB), a comprehensive assessment of cognitive 
performance was completed (Bowie et al., 2012). For VALERO parts 1 and 2, a modified 
version of the MATRICS consensus cognitive battery (MCCB) was used (Bowie et al., 
2008; Durand et al., 2015). In the SCOPE study, we used a further abbreviation of the 
MCCB, based on our interest in social cognition and our goal of examining cognition as a 
composite predictor. In the SCOPE study, we used the BACS Symbol coding test, Trail-
making test part A, Animal naming fluency, The Maryland Letter-Number span test, and the 
Hopkins Verbal learning test as our cognitive battery. This decision was made empirically, 
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on the basis of previously published results regarding the best predictors of composite scores 
on neuropsychological assessments (Keefe et al., 2006) and an analysis of the VALERO I 
data (unpublished) identifying the best predictors of composite performance. In the Mt. 
Sinai study, we examined similar constructs with some slightly different tests: we used the 
WAIS-3 digit symbol task (processing speed), the WAIS-3 letter number span test (working 
memory), and the Hopkins verbal learning test (verbal episodic memory), with animal 
naming and trail-making part A the same as the other studies.
For the analyses developing the cognitive performance latent trait, we used the common 
tests from VALERO I and II and Scope (BACS Symbol coding test, Trail-making test part 
A, Animal naming fluency, The Maryland Letter-Number span test, and the Hopkins Verbal 
learning) and the 5 Mt. Sinai tests to model the cognition latent trait. We chose to model a 
single latent trait because of the limited set of cognition measures and the previous findings 
that these measures had previously been found to be the major contributors to a unifactorial 
factor structure in a large sample of patients with schizophrenia (Keefe et al., 2006). We 
then examined whether the indicators of the latent trait had the same factor loadings, 
correlations with functional capacity and real-world outcomes measures despite subtle 
differences in the tests employed. All cognitive tests results were entered as t-scores, with 
the scores for VALERO I and II and SCOPE based on the MCCB norms and the Mt. Sinai t-
scores based on our previously published normative procedures (Bowie et al., 2008). 
Supplemental Table 1 presents the tests as administered in each of the samples.
2.2.2. Functional Capacity—The brief version of the UCSD Performance-based Skills 
Assessment (UPSA-B) was used to assess functional capacity in all four studies. Participants 
performed everyday tasks related to communication and finances (Patterson et al., 2001). 
During the Communication role-play subtest, participants perform tasks using a telephone 
(e.g., making an emergency call; dialing a number from memory; calling to reschedule a 
doctor’s appointment). For the Finance subtest, participants count change, read a utility bill 
and write and record a check for the bill. The UPSA-B requires approximately 10 minutes to 
complete, and raw scores are converted into a total score ranging from 0–100. Higher scores 
indicate better functional capacity.
2.2.3. Real-World Functional Outcomes—The rating scale employed in these studies 
was the Specific Levels of Functioning (SLOF) scale (Schneider & Struening, 1983). The 
original SLOF is a 43-item self- or informant-rated scale of a person’s behavior and 
functioning which was abbreviated to assess the following domains: Interpersonal 
Functioning (e.g., initiating, accepting and maintaining social contacts; effectively 
communicating), independent participation in Everyday Activities (shopping, using 
telephone, paying bills, use of leisure time, use of public transportation), and Vocational 
Functioning (e.g., employable skills, level of supervision required to complete tasks, ability 
to stay on task, completes tasks, punctuality). The dependent variables for the statistical 
analyses were the scores on these three different subscales. We did not attempt to generate 
an overall composite score because our previous studies with this scale suggested that the 
subscales were differentially correlated with real-world functional milestones (Harvey et al., 
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2011) and our interest was to identify a predictor model aimed at identifying the predictors 
of each aspect of functioning.
2.2.4. Clinical Symptoms—The 21-item Beck Depression Inventory-II (BDI-II; Beck et 
al., 1996) was used to assess the self-reported severity of depression. Severity of psychotic 
and negative symptoms was assessed using the Positive and Negative Syndrome Scale (Kay, 
1991). In a previous study of 3 of the four current samples, we found that only 2 of the 30 
PANSS items were correlated with any of the three elements of functional outcome 
(Robertson et al., 2014). As both of those were negative symptoms, we focused on negative 
symptoms in the present study.
2.3. Statistical Approach
All of the factor analyses performed used the robust full information maximum likelihood 
method of model fitting and parameter estimation (Raykov & Marcoulides, 2008). This 
method fits the model to all subjects and all available data in a data set and accounts for 
some possible violations of normality. Thereby, each subject contributes all his or her 
available data to the model fitting and estimation process (under the widely made 
assumption of data missing at random; e.g., Little & Rubin, 2002). Thus, the fact that some 
subjects had missing values on some of the observed variables involved in the models did 
not lead to dropping any subject from the overall data set.
The strategy we used to examine the predictive relationships of the variables across the 
samples was confirmatory factor analysis. We developed latent traits that reflected 
constructs measured by more than one indicator (e.g., cognition and negative symptoms) and 
examined the similarity of their fit across samples. We then used those latent traits and other 
predictors that were indexed by a single measure (functional capacity and depression) to test 
an a priori theoretical model of the prediction of three observer rated aspects of real-world 
functioning in the community: social functioning, everyday activities, and vocational 
performance, as presented in Figure 1a. For fitting all models, we specified that these 
everyday outcomes were statistically independent from each other. However, the models 
allowed the predictor variables to conform to their observed levels of correlation as they 
were entered in the model.
We also computed a “generic” model, presented in Figure 1b, wherein cognition and 
functional capacity, depression, and negative symptoms were hypothesized to be equally 
important for the prediction of all elements of real-world outcomes in the community. In this 
model we also specified that the real-world outcomes were independent of each other.
The first analyses addressed the single trait model for the cognitive performance variables 
and for the negative symptoms measures. Then the hypothesis driven overall model 
presented in Figure 1a was fitted simultaneously to the data in all 4 groups and tested for 
plausibility. The model was then examined for measurement invariance (i.e., an identical fit) 
in each of the 4 groups. Finally, we fit our “generic prediction model” presented in Figure 
1b in the entire sample and in each subsample. Throughout these analyses for both 
hypothesis driven and generic models, we evaluated fit using the popular root mean square 
error of approximation (RMSEA) and the Comparative fit index (CFI). According to a 
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widely adopted ‘rule-of-thumb’, the value for RMSEA is particularly informative when 
assessing model fit. Specifically, a finding of this index being considerably below .06 is 
indicative of a plausible model (e.g., Raykov & Marcoulides, 2006; Hu & Bentler, 1999). 
CFI indexes are generally seen to be good at over 0.90 and excellent at over 0.95. A 
nonsignificant Chi-square value supports the failure to reject the null hypothesis of model fit 
and usually can be considered an added piece of evidence for plausibility of a model. 
However, we de-emphasize its importance in the present study due to its sizable overall 
sample because the chi-square value with large samples has a tendency to be spuriously high 
(e.g., Bollen, 1989).
In order to compare fit of the generic and hypothesis-driven models, we use the strategy of 
sequential chi-square tests, wherein the chi-square values and degrees of freedom are 
subtracted to directly compare the significance of the difference in fits of the two models, 
both in the entire sample and in each subsample.
3. Results
Demographic data on the four samples are presented in Table 1. Mt. Sinai patients were all 
older than 50, in line with the goal of studying the course of cognitive functioning in older 
patients with a variable history of institutional stay. Other demographic variables are similar 
other than a higher proportion of Hispanic research participants (coming from Miami) in 
VALERO II and SCOPE.
Scores for all real-world functioning variables and their predictors are presented in Table 2. 
All of the between groups differences, calculated with one-way ANOVAs, were statistically 
significant. However, many of the group differences were minimal, and significant only 
because of the substantial sample sizes. The Mt. Sinai patients were less impaired than the 
other samples on social functioning and also had less severe depression and negative 
symptoms. Performance-based variables were remarkably similar across the samples. The 
cognition t scores differed by less than 2 points (0.2 SD) across the samples and the UPSA-
B mean scores were within two points across the samples, despite statistically significant 
differences between the groups. Thus, the clinical, performance-based, and functional 
outcomes variables were minimally variable across the three samples. Pearson correlations 
between all predictor variables are presented in Table 3.
As a next step, we examined the structure of the cognitive performance variables, with the 
aim to find out whether they defined a single latent trait and exhibited measurement 
invariance (a necessary condition for measuring the same trait in the groups: Millsap, 2012). 
The single-trait cognitive hypothesis was found plausible with partial measurement 
invariance. Specifically, within the four groups all 5 factor loadings were constrained for 
equality as were all intercepts except those of trail making part A and multi-trial list 
learning. The corresponding 4-group single-trait cognitive model was associated with 
tenable fit: chi-square (χ2) = 69.198, degrees of freedom (df) = 34, RMSEA = .071 with 
90%-confidence interval (.047, .095), and CFI = .957. We concluded that the dimensional 
structure of our cognitive tests were consistent with a single-latent trait associated with 
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essentially the same measurement structure in all 4 groups, despite the fact that different 
tests were used in the Mt. Sinai sample.
Following these analyses, we examined the latent structure of the negative symptoms 
measures. For these measures, we did not find a version of the single-factor model 
associated with tenable fit. Exploratory factor analyses suggested a lack of 
unidimensionality of these tests in each of the 4 groups, with a consistent finding across the 
groups of a common trait indexed by the symptoms passive-apathetic social withdrawal and 
active social avoidance with no other viable factor structure involving the other 4 items. In 
order to ensure that there were no relationships with other negative symptoms and any of the 
outcomes measures, we performed three stepwise regression analyses in the entire patient 
sample, predicting all three of the outcomes variables with the 7 negative symptoms. For 
everyday activities, no negative symptom measure entered the equation, F(1,818)=1.66, p=.
06. For vocational outcomes, only active social avoidance was a significant predictor in the 
regression, F(1,818)=12.99, p<.001. Finally, for interpersonal functioning, passive-apathetic 
social withdrawal and active social avoidance both entered the equation, F(2, 817)=91.39, <.
001. For these reasons, we included this pair of variables in our confirmatory factor analyses 
as joint indicators of a negative symptoms latent trait.
We next tested the model in Figure 1a. Note that the indicators of real-world community 
functioning are hypothesized to be uncorrelated with each other and that cognitive 
performance is specified as a fully mediated predictor of real-world community outcomes. 
This overall 4-sample model was found to be associated with tenable fit: χ2 = 318.3 df = 
180, RMSEA = .061, CFI = .944. The variance accounted for in interpersonal functioning 
was 23%, while the variance accounted for in everyday activities was 28%, and variance 
accounted for in work functioning was 19%. This model was found to be tenable in each of 
the four samples, as can be seen from the fit indexes presented in Table 4. Thus, the 
hypothesis-driven model was found to fit the data in the entire sample and in each 
subsample.
We then fit the generic model presented in Figure 1b. This model fit the data slightly less 
well than the hypothesis-driven model: χ2 = 355.6, df=192, RMSEA = .064, CFI = .91. 
Variance accounted for in interpersonal functioning was essentially identical at 23%, with 
variance accounted for in everyday activities at 27%, and work functioning at 18%. Thus, 
the more complex model appears to fit the data slightly less well and accounts for the same 
amount of variance in the outcomes variables as the model that hypothesizes more specific 
patterns of correlational influence.
Using the sequential chi-square subtraction procedure, the difference in model fit was 
statistically significant: χ2 =37.3 df=12 (Difference), p=.0002, indicating that the 
hypothesis-driven model was confirmed to be a significantly better fit to the data than the 
generic model. These sequential chi-square subtraction analyses were performed in each of 
the subsamples. In every subsample, the hypothesis driven model was a significantly better 
fit than the generic model, all χ2 (3) > 87.35, all p<.05, suggesting that in the sample as a 
whole and in each subsample, the hypothesis-driven model was a better fit to the data. Note 
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that the generic model, if tested alone, would have been viewed as a reasonable fit to the 
data in these four samples (CFI>0.9; RMSEA<.07).
4. Discussion
Analyses of data from four different samples of people with schizophrenia yielded results 
that may inform attempts to reduce disability in schizophrenia. An overall model was found 
that fit the data and did not differ in its fit across the four separately collected samples. This 
model which specified that negative symptoms were a predictor of the severity of social 
deficits in the overall sample and in each subsample, but did not contribute to predicting 
real-world performance of everyday activities and vocational outcomes, and was a 
significantly better fit than a model that suggested that negative symptoms predicted all 
aspects of functional outcome. Similarly, cognition and functional capacity were predictors 
of the severity of deficits in performing everyday activities and vocational outcomes, but 
would not predict social functioning. Negative symptoms that measure social motivation and 
engagement were related to social outcomes, with other no other negative symptoms 
correlating with any aspect of real world outcomes. Further, no negative symptoms 
manifested any significant correlations with either everyday activities or vocational 
outcomes in zero-order correlational analyses.
The best fitting model also specified that functional capacity exerted its influences on the 
performance of everyday activities and vocational outcomes in a direct manner with 
cognitive deficits exerting their influence entirely through their correlation with functional 
capacity. The hypothesis driven model fit the data significantly better than a generic 
prediction model in in the sample as a whole and in each subsample. However, the generic 
prediction model, with negative symptoms, depression, and cognition/functional capacity 
predicting each element of everyday functioning, would have been viewed as an adequate 
model on its own. Thus, these data should not be interpreted to suggest that negative 
symptoms are completely unrelated to other aspects of outcome, but in our large database, 
the only real-world outcomes that correlated with any of the measured negative symptoms 
was SLOF interpersonal functioning.
The present research methods have several strengths. Individuals who were not aware of the 
results of performance-based assessments and clinical symptoms rated all the real-world 
outcomes. Thus, the resulting correlations are not in any way due to rater overlap. Further, 
the consistent methods across the studies, with quite different characteristics of the samples 
of subjects (Mt. Sinai Sample: all over 50; Miami Samples from VALERO 2 and SCOPE: 
Substantial numbers of Hispanic participants), suggest that the results are generalizable to 
patients with schizophrenia across a variety of demographic sites and treatment settings. 
These results may not apply to inpatients with a more adverse course of illness; however, 
these patients are current rare, typically quite old, or hospitalized for forensic reasons. We 
found a cognitive performance latent trait that was similar across all 4 samples, even though 
slightly different cognitive tests were used in one of the studies. This latent trait is based on 
a small set of cognitive tests and larger cognitive assessment batteries might lead to more 
complex factor structures.
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There are some limitations of these data and these analyses. All patients had to be able to 
participate in an extensive in person assessment. This may have eliminated some patients 
with lower levels of functioning. All patients were selected for having a high contact 
clinician. More extensive cognitive assessments may have led to a more complex factor 
structure. There was no attempt to make the individual samples representative in terms of 
everyday functional outcomes; this concern is obviated by the results of studies of milestone 
achievements in both the Mt. Sinai Sample (Leung et al., 2008), and Valero 1 sample 
(Harvey et al, 2011; Gould et al., 2013) which were quite consistent with normative 
expectations based on multiple earlier studies. Depression was rated with self-report, 
although the correlation with the PANSS depression item in the entire sample was quite 
substantial, r=.64, suggesting that clinical ratings would not have led to different results. 
Meta-analyses have suggested that neurocognitive deficits are less strongly related to social 
deficits, when compared to the influence of social cognition (Fett et al., 2011). We did not 
address social cognition measures because we did not measure social cognition in all of the 
four samples analyzed, cautioning that this dimension (social cognition) might have been 
somewhat related to the negative symptoms’ relationship with interpersonal functioning.
The item content of the negative symptoms and SLOF interpersonal subscale used to assess 
interpersonal skills, and the PANSS negative symptom construct (i.e., initiating and 
maintaining social contacts vs. active social avoidance, blunted affect) has overlap in item 
content, which could clearly affect the strength of the association despite being rated by 
different sources (i.e., clinical raters and other informants). This overlap cannot explain why 
ratings of interpersonal functioning on the SLOF are not correlated with cognition and 
functional capacity in any of the four samples and why cognition and functional capacity so 
consistently correlate with SLOF everyday activities and vocational outcomes. The model 
suggesting that all of the predictor variables (cognition, functional capacity, depression, and 
negative symptoms) are associated with all aspects of outcome (social, vocational, and 
everyday activities) fits the data well enough such that if we had not tested our hypothesis-
driven model we could still have concluded that this model was a good fit to the data.
There are some recent data to which these results could be compared. Galderisi et al. (2014) 
recently performed a multi-site study of real-world community outcomes in a large (N>800) 
sample of Italian outpatients with schizophrenia. They found, similar to our findings, that 
depression was not a major predictor of outcomes and that the influence of cognition on 
everyday outcomes was generally mediated by the influences of functional capacity. A 
critical difference between their study and ours is that they treated everyday outcomes as a 
single latent trait, determined by scores on the same three SLOF subscales that we examined 
in this study. As a result, their findings need to considered in the contest that some studies 
have suggested that the three domains of the SLOF are not highly intercorrelated and that 
the everyday functional milestones underlying those ratings can be unrelated to each other 
(Harvey et al., 2012).
Treatment implications based on these results may be substantial and include proper 
matching of treatments with outcomes targeted. Negative symptoms predicted social 
functioning and cognitive deficits did not in the best fitting model. Thus, cognitive 
rehabilitation treatments might not be expected to improve social functioning if negative 
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symptoms are prominent or not included in the treatment protocol. This finding is consistent 
with the lack of symptomatic benefits, including negative symptoms, found in previous 
meta-analytic studies of cognitive remediation (Wykes et al., 2011). The inverse may be true 
for vocational functioning and the performance of everyday activities. Reductions of 
negative symptoms might not have an immediate beneficial impact on these two everyday 
functional domains. The differential relationships between negative and cognitive 
symptoms, and the outcome domains examined may warrant further research into combining 
various available treatment approaches targeting cognitive and negative symptoms more 
efficiently, perhaps achieving synergistic benefits.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1a. Overall Theoretical Model Tested in Four Samples of Patients with 
Schizophrenia. Figure 1b. Generic Prediction Model
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